Patents Assigned to INSERM (INSTITUT NATIONAL DE LA SAINTE ET DE LA RECHERCHE MEDICALE)
  • COMBINATION OF SPLA2 ACTIVITY AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT.
    Publication number: 20110229919
    Abstract: A method of identifying a subject having or at risk of having or developing a cardiovascular disease and/or a cardiovascular event, includes: measuring, in a sample obtained from the subject, at least two cardiovascular risk factors: a) sPLA2 activity and b) oxidized phospholipids on apolipoprotein B-100 particles (OxPL/apoB), combining the measurements, the combined value of sPLA2 activity and OxPL/apoB being indicative of having or a risk of having or developing a cardiovascular disease and/or cardiovascular event.
    Type: Application
    Filed: October 2, 2009
    Publication date: September 22, 2011
    Applicants: INSERM (INSTITUT NATIONAL DE LA SAINTE ET DE LA RECHERCHE MEDICALE), THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, UNIVERSITE PARIS DIDEROT-PARIS 7
    Inventors: Ziad Mallat, Alain TedguI, Sotirios Tsimikas, Joseph Witztum